Brief: Nordic Nanovector Q2 Total Operating Expenses At NOK 111.0 Mln
Aug 22 (Reuters) - Nordic Nanovector ASA NANOV.OL :
* RESULTS FOR THE SECOND QUARTER AND FIRST HALF 2019
* REVENUES FOR Q2 AMOUNTED TO NOK 0.0 (NOK 0.0 MILLION)
* TOTAL OPERATING EXPENSES FOR Q2 WERE NOK 111.0 MILLION
(NOK 84.5
MILLION)
* COMPREHENSIVE LOSS FOR Q2 AMOUNTED TO NOK 110.4 MILLION
(LOSS OF
NOK 82.9 MILLION)
Source text for Eikon: ID:nObix1qvBa
Further company coverage: NANOV.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln